CNS-Directed Therapy in Young Children with T-Lineage Acute Lymphoblastic Leukemia: High-Dose Methotrexate Versus Cranial Irradiation

Pediatric Blood and Cancer

Volumn 42, Issue 1, 2004, Pages 24-29

  Nathan, Paul C ^a   Maze, Ronnen ^a   Spiegler, Brenda ^a,b   Greenberg, Mark L ^a   Weitzman, Sheila ^a   Hitzler, Johann K ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acute lymphoblastic leukemia; Cranial irradiation; High dose methotrexate; Prophylaxis; T lineage

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN TOXICITY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION; INFUSION; INTERMETHOD COMPARISON; LEUKEMIA REMISSION; LONG TERM CARE; MALE; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RETROSPECTIVE STUDY; SKULL IRRADIATION; T CELL LEUKEMIA;

EID: 0842313006     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10392     Document Type: Article

References (32)

1. Gaynon P, Trigg M, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000;14:2223-2233.
2. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205-2222.
3. LeClerc JM, Billett AL, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol 2002;20:237-246.
4. Relling MV, Rubnitz JE, Rivera GK, et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999;354:34-39.
5. Loning L, Zimmermann M, Reiter A, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy. Blood 2000;95:2770-2775.
6. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 1991;325:1330-1336.
7. Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993;123:59-64.
8. Said JA, Waters BG, Cousens P, et al. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia. J Consult Clin Psychol 1989;57:251-256.
9. Bleyer WA, Fallavollita J, Robison L, et al. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: A report from the Children's Cancer Study Group. Pediatr Hematol Oncol 1990;7:329-338.
10. Matsuzaki A, Ishii E, Nagatoshi Y, et al. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: Results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. Int J Hematol 2001;73:369-377.
11. Stehbens JA, Kaleita TA, Noll RB, et al. CNS prophylaxis of childhood leukemia: What are the long-term neurological, neuropsychological, and behavioral effects? Neuropsychol Rev 1991;2:147-177.
12. Schrappe M, Reiter A, Henze G, et al. Prevention of CNS recurrence in childhood ALL: Results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. Klin Padiatr 1998;210:192-199.
13. Waber DP. More good news about neuropsychogical late effects in long-term survivors of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2002;24:86-87.
14. Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998;92:411-415.
15. Uckun FM, Sensel MG, Sun L, et al. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 1998;91:735-746.
16. Laver JH, Barredo JC, Amylon M, et al. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: A Pediatric Oncology Group report. Leukemia 2000;14:369-373.
17. Amylon MD. Treatment of T-lineage acute lymphoblastic leukemia. Hematol Oncol Clin North Am 1990;4:937-949.
18. Uckun FM, Reaman G, Steinherez PG, et al. Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group Study. Leuk Lymphoma 1996;24:57-70.
19. Steinherz PG, Gaynon PS, Breneman JC, et al. Treatment of patients with acute lymphoblastic leukemia with bulky extra-medullary disease and T-cell phenotype or other poor prognostic features: Randomized controlled trial from the Children's Cancer Group. Cancer 1998;82:600-612.
20. Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999;17:445-455.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:103.
23. Nachman J, Sather H, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998;338:1663-1671.
24. Conter V, Schrappe M, Arico M, et al. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster groups. J Clin Oncol 1997;15:2786-2791.
25. Matherly LH, Taub JW, Wong SC, et al. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Blood 1997;90:578-589.
26. Masson E, Relling MV, Synold TW. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest 1996;97:73-80.
27. Patte C, Kalifa C, Flamant F. Results of the LMT81 protocol, a modified protocol LSAL2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 1992;20:105-113.
28. Millot F, Suciu S, Philippe N, et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. J Clin Oncol 2001;19:1935-1942.
29. Arico M, Basso G, Mandelli F, et al. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer 1995;75:1684-1693.
30. Bettoni C, Reiter M, Schrappe M, et al. Improved event-free survival of childhood T-cell acute lymphoblastic leukemia (T-ALL) after introduction of high dose methotrexate in multicentre trial ALL-BFM 86. Med Pediatr Oncol 1992;20:385.
31. Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study. Leukemia 1999;13:335-342.
32. Nachman J, Sather HN, Cherlow JM, et al. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group. J Clin Oncol 1998;16:920-930.